We used FISH to examine rearrangements in ROS1 and NTRK1, amplification of PDGFRA, KIT, and KDR, and deletion of RB1, and to verify their potential clinical significance in a Brazilian cohort of adult GBM patients (Trevisan et al., 2019). This evidence concerns the gene RB1 and glioblastoma.